GSK 2584786A

Drug Profile

GSK 2584786A

Alternative Names: Adjuvanted quadrivalent influenza vaccine - GlaxoSmithKline; FLU D-QIV-AS03; GSK-2584786A

Latest Information Update: 26 Oct 2016

Price : $50

At a glance

  • Originator GlaxoSmithKline
  • Class Influenza virus vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Influenza virus infections

Most Recent Events

  • 26 Oct 2016 Discontinued - Phase-II for Influenza virus infections (In children, In infants, Prevention) in Finland (IM)
  • 26 Oct 2016 Discontinued - Phase-II for Influenza virus infections (In children, In infants, Prevention) in Spain (IM)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top